This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, March 30, 2009
Sun Pharma announces USFDA approval to market generic Topamax tablets
March 28, 2009: Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market generic Topamax, topiramate tablets.
No comments:
Post a Comment